Planta Med 2022; 88(15): 1577
DOI: 10.1055/s-0042-1759364
Poster Session II

A phenolic-rich extract from Ugni molinae berries reduces abnormal protein aggregation and improve motor behavior in models of huntingtonʼs disease

Authors

  • M Cisternas-Olmedo

    1   Center for Integrative Biology, Chile
    2   Biomedical Neuroscience Institute, Chile
    3   Center for Geroscience, Chile
  • R Perez

    1   Center for Integrative Biology, Chile
    4   Laboratorio de Productos Naturales, Universidad de Chile, Chile
  • M Saez

    1   Center for Integrative Biology, Chile
  • C Delporte

    4   Laboratorio de Productos Naturales, Universidad de Chile, Chile
  • R Vidal

    1   Center for Integrative Biology, Chile
    2   Biomedical Neuroscience Institute, Chile
    3   Center for Geroscience, Chile
 
 

Huntingtonʼs disease (HD) is an autosomal–dominant inherited neurological disorder caused by an unstable trinucleotide CAG repeat expansion at the N-terminus of gene encoding the huntingtin protein (Htt) [1]. The mutation results in Htt proteins with an abnormal length of polyglutamine (polyQ) repeats [2]. This abnormal aggregation of mutant Htt (mHtt) promotes neuronal dysfunction and death of medium spiny neurons in the striatum, resulting in altered motor control and cognitive function [2]. Effective treatments for HD are still pending. Previously, our group identified the presence of polyphenols in leaves from the Chilean-native berry Ugni molinae [3], [4], whose extracts showed a potent anti-aggregation activity in models of Alzheimerʼs disease [4]. However, beneficial effects of murtilla berry extracts were not investigated. Thus, we evaluated the efficacy of fruit extracts from different genotypes of U. molinae on reducing protein aggregation using cellular models of HD [5]. One extract (ETE 19 – 1) significantly reduced polyglutamine aggregation levels.

Aims: To determine the beneficial effect of ETE 19 – 1 extract in HD preclinicals models

Materials & Methods: R6/2 HD mouse model was treated with ETE-19-1 by Gavage daily for one month. We evaluated motor capacity by Rotarod test and protein aggregation in the brain tissue by western blot.

Results: HD preclinical models treated with ETE 19 – 1 shows that improves motor function and reduces protein aggregates in striatum.

Conclusion: Bioactive components in extracts from U. molinae berries have positive effects on HD. This demonstrates the potential effect of native polyphenols to treat neurodegenerative diseases associated with protein aggregates.



Publication History

Article published online:
12 December 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany